Table 2

Procedure characteristics and study outcome

Patient #	Group	Intervention	Technical success	Adverse event	Follow-up (months)	Disease status postendoscopy*	Clinical success	Reintervention
1	Group_DIL	Dilatation	Yes	Lost	Lost	Lost	Lost	Lost
2	Group_DIL	Dilatation	Yes	None	92	Active	No	Surgical resection
3	Group_STENT	Stent	Yes	Pain +Bleeding	91	Remission	Yes	None
4	Group_STENT	Stent	Yes	Pain	91	Remission	No	Surgical resection
5	Group_DIL	Dilatation	Yes	None	87	Remission	No	Re-dilatation
6	Group_STENT	Stent	Yes	Pain	77	Remission	Yes	None
7	Group_DIL	Dilatation	Yes	None	76	Active	No	Surgical resection
8	Group_STENT	Dilatation +Stent	Yes	None	76	Active	Yes	None
9	Group_STENT	Dilatation +Stent	Yes	None	65	Active	Yes	None
10	Group_DIL	Dilation	Yes	None	59	Remission	No	Redilatation
11	Group_STENT	Dilatation +Stent	Yes	None	57	Remission	Yes	None
12	Group_DIL	Dilatation	Yes	None	33	Remission	Yes	None
13	Group_STENT	Dilatation +Stent	Yes	Pain	28	Remission	Yes	None

*The disease status in the strictured region after endoscopy was monitored via imaging, and laboratory tests and based on the findings it was assessed as active (with signs of significant ongoing inflammation) or in remission (without signs of significant ongoing inflammation).